Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
On January 21, 2023, Marianne De Backer, Ph.D., notified us of her decision to
resign from our board of directors as a result of her recent appointment as
Chief Executive Officer of Vir Biotechnology, Inc., and in consideration of her
additional time commitments associated with such position, as well as the
"overboarding" policies of shareholder advisory firms. The effective date of the
resignation has not yet been established, but Dr. De Backer informed us it would
likely be late in the first quarter or in the second quarter of 2023. We will
file an amendment to this current report on Form 8-K to report the effective
date of Dr. De Backer's resignation within four business days of the effective
date being determined.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses